OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Editorial Board	109
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio	95
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”	95
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles	89
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes	86
Editorial Board	79
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations	77
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study	77
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response	74
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment	69
Editorial Board	68
Simplified choice of suitable excipients within biologics formulation design using protein-protein interaction- and water activity-maps	68
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration	67
Topical liquid formulation of bacteriophages for metered-dose spray delivery	66
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery	56
Rationalisation of the purification process for a phage active pharmaceutical ingredient	53
Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids	52
Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: The case of olanzapine	49
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions	48
Question-based review for pharmaceutical development: An enhanced quality approach	46
Homogeneity and mechanical properties of orodispersible films loaded with pellets	45
Unravelling the polysorbate 20 composition: A fusion of UPLC-MS analysis and stochastic modelling	45
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]	45
Long-term exposure in high viscous microenvironment facilitates acquired drug resistance of colon cancer cells to doxorubicin	42
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody	42

Physiologically based biopharmaceutics modeling of regional and colon absorption in humans	41
COSMO models for the pharmaceutical development of parenteral drug formulations	41
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells	40
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study	39
In silico evaluation of corneal patch eluting anti-VEGF agents concept	38
Machine learning driven bioequivalence risk assessment at an early stage of generic drug development	36
Editorial Board	36
Personalised oral dosage forms using an ultra-compact tablet press at the point of care	35
Stearic acid-capped mesoporous silica microparticles as novel needle-like-structured drug delivery carriers	34
Enhancing therapeutic efficacy: In vivo mechanisms and biochemical effects of lycopene encapsulated in nanomicelles for acute inflammation and lipid metabolism	34